The EU approval is the first for the drug, although the FDA in the US is due to deliver its verdict on it by 29th July, and ...

BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary ...

Kymera Therapeutics is celebrating the signing of two partnerships, with Gilead Sciences taking an option on one molecular ...

Liquid biopsies are reshaping colon cancer detection, particularly in addressing the rise in early-onset cases.

Elevidys has been given full approval to treat ambulatory patients with DMD, with an accelerated approval in non-ambulatory ...

That is the conclusion of a study in The Lancet, which has tracked the take-up of childhood vaccinations for diseases like ...

The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...

Trying to tackle all challenges at once will likely cause even more issues in the future; instead of spreading out, focus on ...

Louisiana Senator Bill Cassidy, who chairs the Senate Health, Education, Labor, & Pensions (HELP) Committee, has called for ...

The pharma group has presented phase 1/2 results with new candidate NXT007 at the International Society on Thrombosis and ...

Presenting results from the REDEFINE 1 and REDEFINE 2 studies at the American Diabetes Association (ADA) congress in Chicago, ...

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...